All In Biotech

Drug Trial Radar · NCT02922166

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans

Last checked: Nov 19, 2026Latest source record: Jun 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

36

Actual

Start

Feb 3, 2017

Primary completion

May 10, 2019

Study completion Dec 2019

Sponsor

Lead sponsor
Azevan PharmaceuticalsIndustry
Sponsor type
Industry
Collaborators
National Institute of Mental Health (NIMH)
First posted
Oct 4, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To determine the effects of SRX246 on fear and anxiety based on fear-potentiated startle in humans. Additionally, the effects of the compound on emotion recognition will be explored.

Conditions

  • Fear
  • Anxiety

Interventions

  • SRX246Drug

    oral capsule

  • PlaceboDrug

    oral capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in startle reflex between SRX246 and PlaceboTime frame: up to 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Institute of Mental Health

    Bethesda, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.